Current through February 27, 2024
A pharmacist employed by or contracted with a recovery center
or surgical center for ambulatory patients pursuant to NAC
639.4996 shall:
1. Visit the recovery center or surgical
center at least once each month to:
(a)
Evaluate the effectiveness of the policies and procedures established pursuant
to NAC 639.4996; and
(b) Confirm that the recovery center or
surgical center is complying with those policies and procedures, the provisions
of this section and NAC
639.4996;
2. Maintain documentation of each visit that
the pharmacist makes pursuant to subsection 1;
3. Conduct an audit at least once each month
using a sufficient number of records of the recovery center or surgical center,
including, without limitation, records of patients and records relating to the
purchasing, storing and dispensing of drugs and investigational drugs, which
must be randomly selected, to determine whether:
(a) The records indicate that the drugs and
investigational drugs are dispensed in a safe and effective manner in
accordance with accepted standards of practice and the specifications of the
manufacturer;
(b) Drugs and
investigational drugs are diluted in accordance with accepted standards of
practice or pursuant to the specifications of the manufacturer;
(c) The records demonstrate:
(1) That a discrepancy does not exist in the
number of drugs and investigational drugs that are in vials designated by the
manufacturer for a single use which are dispensed and the number of patients
who receive such drugs and investigational drugs; and
(2) That drugs, not including investigational
drugs, which are in vials designated by the manufacturer for a single use and
any remaining medication in those vials are discarded after use;
(d) The records demonstrate that
drugs, not including investigational drugs, which are in vials designated by
the manufacturer for more than one use are discarded when the medication in the
vials has expired or not more than 28 days after the initial breach of the
vial;
(e) The employees of the
recovery center or surgical center properly maintain accurate records relating
to drugs and investigational drugs; and
(f) The employees of the recovery center or
surgical center properly monitor and maintain the perpetual inventory required
pursuant to paragraph (d) of subsection 1 of NAC
639.4996; and
4. Submit a written report,
including, without limitation, a written explanation, to the Board not later
than 5 business days after the pharmacist determines that:
(a) The recovery center or surgical center is
violating a state or federal law which affects the care and safety of a
patient;
(b) There is a discrepancy
of 5 percent or more between the actual quantity of a controlled substance in
the possession of the recovery center or surgical center and the amount of the
controlled substance that should be in the possession of the recovery center or
surgical center according to the records of the recovery center or surgical
center, including, without limitation:
(1)
Purchase orders and invoices for the controlled substance;
(2) Records which indicate the removal of the
controlled substance from the storage area;
(3) Patient records;
(4) Records which indicate the return of the
controlled substance to the manufacturer;
(5) Records which indicate that the
controlled substance was destroyed; and
(6) Any other record for the controlled
substance;
(c) The
recovery center or surgical center has intentionally or recklessly failed to
create or maintain a record required by the policies and procedures established
pursuant to NAC
639.4996;
(d) The recovery center or surgical center is
administering a drug or an investigational drug in violation of accepted
standards of practice or the specifications of the manufacturer; or
(e) The recovery center or surgical center is
engaged in a practice which endangers the health, safety or welfare of a
patient or employee of the recovery center or surgical center.
Added to NAC by Bd. of
Pharmacy by R116-08, eff. 9-18-2008; A by
R085-20A,
eff. 2/25/2021
NRS
639.070,
639.071
